ACTO Technologies

Overview

ACTO Technologies, founded in 2014 and based in Canada, operates within the software industry, specifically focusing on content and collaboration software tailored for the biopharmaceutical sector. The company employs between 51 and 200 individuals and has reported revenue of approximately $12.6 million. ACTO's primary offering, TalkTRx™, is designed to enhance the effectiveness of field representatives in their interactions with healthcare professionals (HCPs). The solution addresses the challenge of ensuring that biopharma reps can accurately communicate key messages and clinical evidence from marketing materials during face-to-face engagements. The company emphasizes the importance of message accuracy and the effective use of digital content, noting that a significant portion of produced materials remains underutilized by field teams. By providing resources such as key takeaways, best practice tips, and instructional videos, TalkTRx™ aims to increase reps' confidence and competence in utilizing approved assets, ultimately enhancing the consistency of brand messaging and improving patient engagement outcomes.

Industry